Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera Announces Publication Of Long-Term Clinical Data With Vamorolone

Sept 22 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * SANTHERA ANNOUNCES PUBLICATION OF LONG-TERM CLINICAL DATA
WITH
VAMOROLONE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
    * LONG-TERM STUDY SHOWED SIGNIFICANT CONTINUED CLINICAL
IMPROVEMENT OF ALL OUTCOMES MEASURED OVER AN 18-MONTH FOLLOW-UP
PERIOD

Source text for Eikon:  ID:nGNE2hSGx7 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news